PSA: if you get covid and in bad shape you can now get leronlimab at one of the trial sites even though the trial is fully enrolled. The FDA just allowed open- label arm extension. It is a pretty good sign that leronlimab is helping severe/critical patients.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links